Eurobio Scientific Société anonyme (EPA:ALERS)

France flag France · Delayed Price · Currency is EUR
23.30
-0.10 (-0.43%)
Mar 4, 2026, 4:43 PM CET
-8.09%
Market Cap 235.60M
Revenue (ttm) 162.47M
Net Income (ttm) 2.36M
Shares Out 10.07M
EPS (ttm) 0.22
PE Ratio 104.28
Forward PE 30.00
Dividend n/a
Ex-Dividend Date n/a
Volume 2,416
Average Volume 1,757
Open 23.30
Previous Close 23.40
Day's Range 23.20 - 23.65
52-Week Range 21.80 - 25.95
Beta 0.65
RSI 47.76
Earnings Date Apr 10, 2026

About EPA:ALERS

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, for heart transplant monitoring; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients’ immune stat... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1997
Employees 380
Stock Exchange Euronext Paris
Ticker Symbol ALERS
Full Company Profile

Financial Performance

In 2024, EPA:ALERS's revenue was 154.95 million, an increase of 18.60% compared to the previous year's 130.65 million. Earnings were 4.00 million, a decrease of -17.31%.

Financial Statements

News

There is no news available yet.